234 related articles for article (PubMed ID: 14655194)
41. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
[TBL] [Abstract][Full Text] [Related]
42. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
43. Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.
Drüeke T; Bordier PJ; Man NK; Jungers P; Marie P
Kidney Int; 1977 Apr; 11(4):267-74. PubMed ID: 857076
[TBL] [Abstract][Full Text] [Related]
44. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
[TBL] [Abstract][Full Text] [Related]
45. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Rodriguez AP; Felsenfeld AJ
J Bone Miner Res; 1997 Mar; 12(3):347-55. PubMed ID: 9076577
[TBL] [Abstract][Full Text] [Related]
46. [Long-term treatment with large doses of alphacalicidol in secondary hyperparathyroidism of patients dialyzed for end stage renal failure].
Matuszkiewicz-Rowińska J; Niemczyk S; Pacocha E; Puka J; Switalski M; Bogdańska-Straszyńska B; Ostrowski K
Pol Arch Med Wewn; 1996 Jul; 96(1):15-22. PubMed ID: 8966141
[TBL] [Abstract][Full Text] [Related]
47. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
48. Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD.
Wetmore JB; Santos PW; Mahnken JD; Krebill R; Menard R; Gutta H; Quarles LD
J Clin Endocrinol Metab; 2011 Jan; 96(1):E57-64. PubMed ID: 20943782
[TBL] [Abstract][Full Text] [Related]
49. Dynamic follow-up of the intact parathormone levels in hemodialysis patients treated with Rocaltrol and calcium.
Dimitrakov D; Koumtchev E; Dimitrova R; Stavrev P
Folia Med (Plovdiv); 1998; 40(4):48-53. PubMed ID: 10371800
[TBL] [Abstract][Full Text] [Related]
50. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
[TBL] [Abstract][Full Text] [Related]
51. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis.
Holgado R; Haire H; Ross D; Sprague S; Pahl M; Jara A; Martin-Malo A; Rodriguez M; Almaden Y; Felsenfeld AJ
J Bone Miner Res; 2000 May; 15(5):927-35. PubMed ID: 10804023
[TBL] [Abstract][Full Text] [Related]
52. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
Quarles LD; Yohay DA; Carroll BA; Spritzer CE; Minda SA; Bartholomay D; Lobaugh BA
Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819
[TBL] [Abstract][Full Text] [Related]
53. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
[TBL] [Abstract][Full Text] [Related]
54. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
[TBL] [Abstract][Full Text] [Related]
55. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
Messa P; Mioni G; Turrin D; Guerra UP
Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
[TBL] [Abstract][Full Text] [Related]
56. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
[TBL] [Abstract][Full Text] [Related]
57. Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level.
Chagnac A; Ori Y; Weinstein T; Zevin D; Korzets A; Hirsh J; Edelstein S; Gafter U
J Am Soc Nephrol; 1997 Oct; 8(10):1579-86. PubMed ID: 9335387
[TBL] [Abstract][Full Text] [Related]
58. Dynamic tests of parathyroid hormone secretion using hemodialysis and calcium infusion cannot be compared.
Moysés RM; Pereira RC; Machado dos Reis L; Sabbaga E; Jorgetti V
Kidney Int; 1999 Aug; 56(2):659-65. PubMed ID: 10432406
[TBL] [Abstract][Full Text] [Related]
59. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
Fehr T; Garzoni D; Staub T; Binet I; Wüthrich RP
Kidney Blood Press Res; 2006; 29(3):175-81. PubMed ID: 16931896
[TBL] [Abstract][Full Text] [Related]
60. The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure.
Cardinal H; Brossard JH; Roy L; Lepage R; Rousseau L; D'Amour P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3839-44. PubMed ID: 9814455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]